BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12970392)

  • 1. Neuropeptide Y receptor-mediated sensitization of ATP-stimulated inositol phosphate formation.
    Drakulich DA; Walls AM; Toews ML; Hexum TD
    J Pharmacol Exp Ther; 2003 Nov; 307(2):559-65. PubMed ID: 12970392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y enhances ATP-induced formation of inositol phosphates in chromaffin cells.
    Zheng J; Zhang P; Toews M; Hexum TD
    Biochem Biophys Res Commun; 1997 Oct; 239(1):287-90. PubMed ID: 9345312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Betagamma subunits mediate the NPY enhancement of ATP-stimulated inositol phosphate formation.
    Li X; Ikezu T; Hexum TD
    Peptides; 2004 Feb; 25(2):267-74. PubMed ID: 15063008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y and the retinal pigment epithelium: receptor subtypes, signaling, and bioelectrical responses.
    Ammar DA; Hughes BA; Thompson DA
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1870-8. PubMed ID: 9727410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular signaling mechanisms mediating catecholamine release upon activation of NPY Y1 receptors in mouse chromaffin cells.
    Rosmaninho-Salgado J; Araújo IM; Alvaro AR; Duarte EP; Cavadas C
    J Neurochem; 2007 Nov; 103(3):896-903. PubMed ID: 17868303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of G-protein beta gamma subunits in the augmentation of P2Y2 (P2U)receptor-stimulated responses by neuropeptide Y Y1 Gi/o-coupled receptors.
    Selbie LA; King NV; Dickenson JM; Hill SJ
    Biochem J; 1997 Nov; 328 ( Pt 1)(Pt 1):153-8. PubMed ID: 9359846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on neuropeptide Y receptors in a mouse adrenocortical cell line.
    Weng G; Yee F; Michl P; Reis D; Wahlestedt C
    Mol Pharmacol; 1995 Jul; 48(1):9-14. PubMed ID: 7623780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpression of Y1, Y2, and Y4 receptors in smooth muscle coupled to distinct signaling pathways.
    Misra S; Murthy KS; Zhou H; Grider JR
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1154-62. PubMed ID: 15308651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y inhibits chromaffin cell nicotinic receptor-stimulated tyrosine hydroxylase activity through a receptor-linked G protein-mediated process.
    Zheng J; Zhang P; Hexum TD
    Mol Pharmacol; 1997 Dec; 52(6):1027-33. PubMed ID: 9415712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the C terminus in neuropeptide Y Y1 receptor desensitization and internalization.
    Holliday ND; Lam CW; Tough IR; Cox HM
    Mol Pharmacol; 2005 Mar; 67(3):655-64. PubMed ID: 15576634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y rapidly enhances [Ca2+]i transients and Ca2+ sparks in adult rat ventricular myocytes through Y1 receptor and PLC activation.
    Heredia Mdel P; Delgado C; Pereira L; Perrier R; Richard S; Vassort G; Bénitah JP; Gómez AM
    J Mol Cell Cardiol; 2005 Jan; 38(1):205-12. PubMed ID: 15623437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP stimulated cyclic AMP formation in bovine chromaffin cells is enhanced by neuropeptide Y.
    Zhang P; Zheng J; Bradley ME; Hexum TD
    Peptides; 2001 Mar; 22(3):439-44. PubMed ID: 11287099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y induced attenuation of catecholamine synthesis in the rat mesenteric arterial bed.
    Westfall TC; Naes L; Gardner A; Yang CL
    J Cardiovasc Pharmacol; 2006 Jun; 47(6):723-8. PubMed ID: 16810071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y inhibition of nicotinic receptor-mediated chromaffin cell secretion.
    Hexum TD; Zheng J; Zhu J
    J Pharmacol Exp Ther; 1994 Oct; 271(1):61-6. PubMed ID: 7965758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors.
    Dimitrijević M; Stanojević S; Vujić V; Beck-Sickinger A; von Hörsten S
    Regul Pept; 2005 Jan; 124(1-3):163-72. PubMed ID: 15544855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an NPY-Y1 receptor subtype in bovine chromaffin cells.
    Zhang P; Zheng J; Vorce RL; Hexum TD
    Regul Pept; 2000 Feb; 87(1-3):9-13. PubMed ID: 10710282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of neuropeptide Y Y1 receptors in the regulation of LH and GH cells in the pituitary of the catfish, Clarias batrachus: an immunocytochemical study.
    Mazumdar M; Lal B; Sakharkar AJ; Deshmukh M; Singru PS; Subhedar N
    Gen Comp Endocrinol; 2006 Nov; 149(2):190-6. PubMed ID: 16828090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of neuropeptide Y Y1 receptors inhibits glutamate release through reduction of voltage-dependent Ca2+ entry in the rat cerebral cortex nerve terminals: suppression of this inhibitory effect by the protein kinase C-dependent facilitatory pathway.
    Wang SJ
    Neuroscience; 2005; 134(3):987-1000. PubMed ID: 16026936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen up-regulates neuropeptide Y Y1 receptor expression in a human breast cancer cell line.
    Amlal H; Faroqui S; Balasubramaniam A; Sheriff S
    Cancer Res; 2006 Apr; 66(7):3706-14. PubMed ID: 16585197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of BIBP3226 on inositol phosphate accumulation and cytosolic calcium level in control and NPY Y1 receptor expressing CHO-K1 cells.
    Vanderheyden PM; Van Liefde I; DeBacker JP; Ebinger G; Vauquelin G
    Regul Pept; 1998 Sep; 75-76():191-9. PubMed ID: 9802409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.